Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Return on Sales (2016 - 2025)

Plus Therapeutics has reported Return on Sales over the past 13 years, most recently at 0.04% for Q4 2025.

  • Quarterly Return on Sales fell 1.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2025, down 1.0% year-over-year, with the annual reading at 0.03% for FY2025, 1.0% down from the prior year.
  • Return on Sales was 0.04% for Q4 2025 at Plus Therapeutics, down from 0.03% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q3 2023 and troughed at 0.72% in Q3 2022.
  • The 4-year median for Return on Sales is 0.03% (2023), against an average of 0.1%.
  • The largest YoY upside for Return on Sales was 71bps in 2023 against a maximum downside of -6bps in 2023.
  • A 4-year view of Return on Sales shows it stood at 0.44% in 2022, then skyrocketed by 93bps to 0.03% in 2023, then rose by 5bps to 0.03% in 2024, then plummeted by -51bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Return on Sales are 0.04% (Q4 2025), 0.03% (Q3 2025), and 0.01% (Q2 2025).